4SC Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Jason Loveridge
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7.8yrs |
| CEO ownership | n/a |
| Management average tenure | 7.8yrs |
| Board average tenure | 16.4yrs |
Recent management updates
No updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -€8m |
| Mar 31 2024 | n/a | n/a | -€8m |
| Dec 31 2023 | n/a | n/a | -€8m |
| Sep 30 2023 | n/a | n/a | -€8m |
| Jun 30 2023 | n/a | n/a | -€8m |
| Mar 31 2023 | n/a | n/a | -€11m |
| Dec 31 2022 | n/a | n/a | -€14m |
| Sep 30 2022 | n/a | n/a | -€19m |
| Jun 30 2022 | n/a | n/a | -€23m |
| Mar 31 2022 | n/a | n/a | -€16m |
| Dec 31 2021 | €519k | €400k | -€10m |
| Sep 30 2021 | n/a | n/a | -€8m |
| Jun 30 2021 | n/a | n/a | -€7m |
| Mar 31 2021 | n/a | n/a | -€13m |
| Dec 31 2020 | €716k | €400k | -€19m |
| Sep 30 2020 | n/a | n/a | -€19m |
| Jun 30 2020 | n/a | n/a | -€19m |
| Mar 31 2020 | n/a | n/a | -€16m |
| Dec 31 2019 | €679k | €377k | -€14m |
| Sep 30 2019 | n/a | n/a | -€15m |
| Jun 30 2019 | n/a | n/a | -€17m |
| Mar 31 2019 | n/a | n/a | -€17m |
| Dec 31 2018 | €669k | €340k | -€18m |
| Sep 30 2018 | n/a | n/a | -€15m |
| Jun 30 2018 | n/a | n/a | -€12m |
| Mar 31 2018 | n/a | n/a | -€11m |
| Dec 31 2017 | €539k | €340k | -€11m |
Compensation vs Market: Insufficient data to establish whether Jason's total compensation is reasonable compared to companies of similar size in the German market.
Compensation vs Earnings: Jason's compensation has been consistent with company performance over the past year.
CEO
Jason Loveridge
7.8yrs
Tenure
€519,000
Compensation
Dr. Jason Loveridge, B.Sc, Ph D, FRSM, has been Corporate Advisor of Resonance Health Limited since June 30, 2017. Dr. Loveridge is a Founder of Invex.Dr. Loveridge has been Chairman of Management Board a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of Management Board | 7.8yrs | €519.00k | no data | |
| COO & Member of the Management Board | 2yrs | no data | no data | |
| Corporate Communications & Investor Relations Officer | no data | no data | no data | |
| Chief Medical Officer | 9.6yrs | no data | no data | |
| Team Assistant | no data | no data | no data |
7.8yrs
Average Tenure
Experienced Management: VSC's management team is seasoned and experienced (7.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Deputy Chairman of Supervisory Board | 19.3yrs | €37.00k | no data | |
| Independent Chairman of Supervisory Board | 19.3yrs | €64.00k | no data | |
| Independent Member of Supervisory Board | 16.4yrs | €23.00k | no data | |
| Independent Member of Supervisory Board | 12.3yrs | €33.00k | no data | |
| Independent Member of Supervisory Board | 10.8yrs | €37.00k | no data | |
| Member International Scientific Expert Panel | no data | no data | no data | |
| Member International Scientific Expert Panel | no data | no data | no data |
16.4yrs
Average Tenure
60yo
Average Age
Experienced Board: VSC's board of directors are seasoned and experienced ( 16.4 years average tenure).